Delivery of Interferon-γ by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways

Journal of Neuroimmunology

Volumn 206, Issue 1-2, 2009, Pages 39-43

  Carr, Daniel J J ^a   Austin, Bobbie A ^a   Halford, William P ^b   Stuart, Patrick M ^c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CXCL10; HSV 1; IFN ; IFN

Indexed keywords

ADENOVIRUS VECTOR; BETA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; PROTEIN KINASE R; RIBONUCLEASE L;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; HERPES SIMPLEX VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SENSORY GANGLION; SIGNAL TRANSDUCTION; TRANSGENE; ULTRAVIOLET RADIATION; VIROGENESIS; VIRUS EXPRESSION; VIRUS INACTIVATION; VIRUS INHIBITION;

ANALYSIS OF VARIANCE; ANIMALS; CYTOKINES; EIF-2 KINASE; ENDORIBONUCLEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC VECTORS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; INTERFERON-BETA; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TIME FACTORS; TRANSDUCTION, GENETIC; ULTRAVIOLET RAYS; VIRUS ACTIVATION;

EID: 58149477515     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.10.008     Document Type: Article

References (39)

1. Al-khatib K., Williams B.R.G., Silverman R.H., Halford W., and Carr D.J.J. The murine double-stranded RNA-dependent protein kinase PKR and the murine 2′,5′-oligoadenylate synthetase-dependent RNase L are required for IFN-β-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture. Virology 313 (2003) 126-135
2. Al-khatib K., Williams B.R.G., Silverman R.H., Halford W., and Carr D.J.J. Distinctive roles for 2′,5′-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-β. J. Immunol. 172 (2004) 5638-5647
3. Austin B.A., James C., Silverman R.H., and Carr D.J.J. Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-β during acute ocular herpes simplex virus type 1 infection. J. Immunol. 175 (2005) 1100-1106
4. Austin B.A., Halford W., Silverman R.H., Williams B.R.G., and Carr D.J.J. OAS and PKR are not required for the antiviral effect of Ad:IFN-γ against acute HSV-1 in primary trigeminal ganglia cultures. J. Interferon Cytokine Res. 26 (2006) 220-225
5. + T cells are required foradenovirus vector: IFN-γ inhibition of herpes simplex virus-1 in cornea. J. Immunol. 178 (2007) 5166-5172
6. Biron C.A. Interferons alpha and beta as immune regulators - a new look. Immunity 14 (2001) 661-664
7. Cantin E.M., Hinton D.R., Chen J., and Openshaw H. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69 (1995) 4898-4905
8. Cantin E., Tanamachi B., and Openshaw H. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J. Virol. 73 (1999) 3418-3423
9. Carr D.J.J., and Tomanek L. Herpes simplex virus and the chemokines that mediate the inflammation. CTMI 303 (2006) 47-65
10. Chou J., Chen J.J., Gross M., and Roizman B. Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 1 34.5 mutants of herpes simplex virus 1. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 10516-10520
11. Corey L., and Spear P.G. Infections with herpes simplex viruses (1). N. Engl. J. Med. 314 (1986) 686-691
12. Croen D.K., Ostrove J.M., Smialek L.J., and Straus S.E. Latent herpes simplex virus in human trigeminal ganglia: detection of an immediate early gene 'antisense' transcript by in situ hybridization. N. Engl. J. Med. 317 (1987) 1427-1432
13. Decman V., Kinchington P.R., Harvey S.A.K., and Hendricks R.L. Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J. Virol. 79 (2005) 10339-10347
14. Feldman J.T., Ellison A.R., Voytek C.C., Yang L., Krause P., and Margolis T.P. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 978-983
15. Halford W.P., Gebhardt B.M., and Carr D.J.J. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J. Immunol. 157 (1996) 3542-3549
16. Halford W.P., Gehbardt B.M., and Carr D.J.J. Mechanisms of herpes simplex virus type 1 reactivation. J. Virol. 70 (1996) 5051-5060
17. Halford W.P., Weisend C., Grace J., Soboleski M., Carr D.J.J., Balliet J.W., Imai Y., Margolis T.P., and Gebhardt B.M. ICP0 antagonizes Stat I-dependent repression of herpes simplex virus: implications for the regulation of viral latency. Virol. J. 3 (2006) 44
18. Härle P., Cull V., Abgaga M.-P., Silverman R., Williams B.R.G., James C., and Carr D.J.J. Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. J. Virol. 76 (2002) 6558-6567
19. Keadle T.L., Morrison L.A., Morris J.L., Pepose J.S., and Stuart P.M. Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection. J. Virol. 76 (2002) 3615-3625
20. + T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18 (2003) 593-603
21. Kolumam G.A., Thomas S., Thompson L.J., Sprent J., and Murali-Krishna K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202 (2005) 6370650
22. Kriesel J.D., Gebhardt B.M., Hill J.M., Maulden S.A., Hwang I.P., Clinch T.E., Cao X., Spruance S.L., and Araneo B.A. Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation. J. Infect. Dis. 175 (1997) 821-827
23. + T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4 (2003) 1009-1015
24. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 20 (2001) 1-13
25. Liu T., Tang Q., and Hendricks R.L. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70 (1996) 264-271
26. + T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191 (2000) 1459-1466
27. Margolis T.P., Imai Y., Yang L., Vallas V., and Krause P.R. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. J. Virol. 81 (2007) 1872-1878
28. Mossman K.L., and Smiley J.R. Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J. Virol. 76 (2002) 1995-1998
29. Noisakran S., and Carr D.J.J. Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia. J. Neuroimmunol. 95 (1999) 126-135
30. Noisakran S., Halford W.P., Veress L., and Carr D.J.J. Role of the hypothalamic pituitary adrenal axis and IL-6 in stress-induced reactivation of latent herpes simplex virus type 1. J. Immunol. 160 (1998) 5441-5447
31. Richards C.M., Case R., Hirst T.R., Hill T.J., and Williams N.A. Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice. J. Virol. 77 (2003) 6692-6699
32. + T cell memory. J. Immunol. 177 (2006) 8356-8364
33. Shimeld C., Whiteland J.L., Nicholls S.M., Grinfeld E., Easty D.L., Gao H., and Hill T.J. Immune cell infiltration and persistence in the mouse trimgeminal ganglion after infection of the cornea with herpes simplex virus type 1. J. Neuroimmunol. 61 (1995) 7-16
34. Shimeld C., Whiteland J.L., Nicholls S.M., Easty D.L., and Hill T.J. Immune cell infiltration in corneas of mice with recurrent herpes simplex virus disease. J. Gen. Virol. 77 (1996) 977-985
35. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Ann. Rev. Biochem. 67 (1998) 227-264
36. Stevens J.G., Wagner E.K., Devi-Rao G.B., Cook M.L., and Feldman L.T. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235 (1987) 1056-1059
37. Theil D., Derfuss T., Paripovic I., Herberger S., Meinl E., Schueler O., Strupp M., Arbusow V., and Brandt T. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am. J. Pathol. 163 (2003) 2179-2184
38. Torterella D., Gewurz B.E., Furman M.H., Schust D.J., and Ploegh H.L. Viral subversion of the immune system. Ann. Rev. Immunol. 18 (2000) 861-926
39. Yokota S., Yokosawa N., Okabayashi T., Suzutani T., Miura S., Jimbow K., and Fujii N. Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J. Virol. 78 (2004) 6282-6286